M/19/046 - Recipharm/Consort [2020] IECompA m19046 (28 January 2020)

M/19/046 - Recipharm/Consort [2020] IECompA m19046 (28 January 2020)

The proposed acquisition does not raise competition concerns as Recipharm has no manufacturing or development facilities in the State and the overlap in activities is limited to sales, thus the transaction is cleared.

Parties
Acquirer: Recipharm Holdings Limited; Target: Consort Medical Plc
Jurisdiction
Ireland
Judgment Date
28 January 2020
Procedural Posture
Merger Notification / Phase 1 Clearance
Outcome
cleared
Legal Topics
Merger Control, Pharmaceutical Industry, Acquisition Clearance
Competition Law Merger Control Pharmaceutical Industry Acquisition Clearance

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 1 Authorities cited 1 Party arguments 2
Sign in to unlock

Parties

Recipharm Holdings Limited

Acquirer

Consort Medical Plc

Target

Procedural Posture

Merger Notification / Phase 1 Clearance

Legal Issues

  1. 1 Whether the proposed acquisition would substantially lessen competition in any market for goods or services in the State.

Ratio Decidendi

The proposed acquisition does not raise competition concerns as Recipharm has no manufacturing or development facilities in the State and the overlap in activities is limited to sales, thus the transaction is cleared.

Court Disposition

cleared

Orders

  • The proposed acquisition is cleared by the Competition and Consumer Protection Commission.